Inflammasome Therapeutics Inc
Dr. Lee is CEO of Taejoon Pharmaceutical Co., Ltd., a specialty ophthalmology company based in South Korea. He earned his Ph.D. in Immunology/Biology from The Scripps Research Institute and his Master of Science from Seoul National University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Inflammasome Therapeutics Inc
Inflammasome Therapeutics Inc found to develop therapies for prevalent, degenerative diseases.